Blueberries Medical Corp., a licensed producer of cannabis derivatives in Colombia, announced a non-brokered private placement raising approximately C$1.1 million by selling 84.6 million common shares at C$0.013 each. The funds will be used to expand operations, support general corporate needs, and enhance working capital. The offering is expected to close around August 26, 2026, and is led by Terraflos Inc., a key investor controlled by Blueberries' CEO. This financing supports Blueberries' growth in health, wellness, and longevity sectors through scalable production of plant-based bioactives and cannabis products.
THOR Industries reported Q4 earnings with an EPS of $0.78, missing analyst estimates and showing a 66.9% drop from last year. Despite this, the company beat revenue expectations with $2.31 billion, though revenue declined 8.4% year-over-year due to w...
Cracker Barrel Old Country Store is set to report its Q3 2026 earnings on September 23, with analysts predicting a significant decline. Earnings per share are expected to fall to $0.17 from $0.74 last year, and revenue is forecasted around $834.57 mi...
Abivax received positive pre-NDA feedback from the U.S. FDA for its drug Obefazimod, marking a key step in its development. Despite a recent price target cut by Wedbush to $118, analysts maintain a "Moderate Buy" consensus with an average target of $...
HSBC and Wells Fargo have downgraded Netflix stock due to declining subscriber engagement and an 8% drop in viewership time. Despite a recent 2.19% stock gain, Netflix shares have fallen over 40% in the past year amid strong competition and weaker or...
A director at FormFactor sold 2,100 shares, indicating a notable insider transaction. Such sales can reflect personal financial decisions or strategic portfolio adjustments by company insiders. Investors often watch these moves for potential signals ...
